Abstract:Background: Glomerular disease, often characterized by podocyte injury and proteinuria, can lead to chronic kidney disease and end stage kidney disease. We hypothesized that the glomerular pathophysiology is associated with alternative mRNA processing, such as alternative splicing (AS) and polyadenylation (APA), of glomerular genes and especially of critical podocyte, slit diaphragm and matrix genes that regulate the glomerular filtration barrier. Methods: Glomerular damage, accompanied with proteinuria, hypoalbuminemia and hypercholesterolemia was induced by puromycin aminonucleoside (PAN) or adriamycin (ADR) to mimic human minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS), respectively. Glomerular RNA-seq analyses was performed followed by JunctionSeq and APATrap bioinformatics analyses to detect AS and APA events, respectively. Novel splice sites and poly(A) usage sites and differences in alternatively spliced and polyadenylated isoforms were queried in JunctionSeq and APATrap pipelines. Results: Altered glomerular mRNA processing by AS/APA was identified in 136/71 and 1875/746 genes in MCD and FSGS models, respectively. Transcript annotation and prioritization of significant AS and APA identified key events in genes with novel and established roles that cause disruption in the glomerular filtration barrier. These events localized in the regions of slit diaphragm (NPHS1, NPHS2, NEPH1, ZO1, ITM2B), glomerular basement membrane (COL4A3/4/5, LAMB2, LAMA5), podocyte mitochondria (COQ2), podocyte membrane (PODXL) and endothelial cells (INF2). Concomitantly, numerous polyadenylation and splicing factors which could serve as potential trans- factors that lead to AS and APA, were dysregulated in these two models of glomerular nephropathies. Additionally, beneficial proteinuria reducing treatment modalities, pioglitazone and GQ16 reversed many of these AS and APA events. Moreover, suggestive GWAS SNPs were identified in many of these genes from human nephrotic syndrome database, which could potentially serve as cis- factors that lead to AS and APA, and downstream functional effects. Conclusion: Findings from our studies shed light on a new landscape of research in glomerular pathophysiology, i.e., AS and APA of glomerular genes, many of which are crucial determinants of podocyte structure and function, slit diaphragm complex, and glomerular basement membrane. These findings present new implications for improved mechanistic understanding of glomerular disease and development of novel therapeutic intervention strategies.

Mice with a Pax2 missense variant display impaired glomerular repair

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Papillorenal Syndrome-Causing Missense Mutations in PAX2/Pax2 Result in Hypomorphic Alleles in Mouse and Human

The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury.

A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury

Distinct Functional Requirements for Podocalyxin in Immature and Mature Podocytes Reveal Mechanisms of Human Kidney Disease

Renin‐angiotensin blockade ameliorates the progression of glomerular injury in podocyte‐specific Ctcf knockout mice

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

Protein phosphatase 2A modulates podocyte maturation and glomerular functional integrity in mice

Blocking Ribosomal Protein S6 Phosphorylation Inhibits Podocyte Hypertrophy and Focal Segmental Glomerulosclerosis.

Abstract P127: Microrna-204 Protects Against Angiotensin II-induced Apoptosis in Podocytes Via Sox4

Conditional ablation of glycogen synthase kinase 3 β in postnatal mouse kidney

Glomerular Elasticity and Gene Expression Patterns Define Two Phases of Alport Nephropathy

Inhibiting calpain 1 and 2 in cyclin G associated kinase–knockout mice mitigates podocyte injury

Missense Mutant Gain-of-Function Causes Inverted Formin 2 (INF2)-Related Focal Segmental Glomerulosclerosis (FSGS)

Podocyte-specific RAP1GAP Expression Contributes to Focal Segmental Glomerulosclerosis-Associated Glomerular Injury.

Podocyte-Specific Deletion of MCP-1 Fails to Protect against Angiotensin II- or Adriamycin-Induced Glomerular Disease

Alternative mRNA Splicing and Polyadenylation Events are Synchronous with Podocyte Injury and Slit Diaphragm Dysregulation in Glomerular Disease Models

Global Transcriptomic Changes in Glomerular Endothelial Cells in Mice with Podocyte Depletion and Glomerulosclerosis

Dissection of Glomerular Transcriptional Profile in Patients with Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.

De novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.